Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.94 USD | +4.29% | +7.36% | -2.32% |
04-11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
03-22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.32% | 387M | |
+33.43% | 700B | |
+27.89% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.23% | 236B | |
+6.79% | 202B | |
-9.41% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow Health's Eye Treatment Drug Vevye Now Available in US